OptimizeRx Corporation (OPRX) NASDAQ
6.21
-0.23(-3.57%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.21
-0.23(-3.57%)
Currency In USD
| Previous Close | 6.44 |
| Open | 6.39 |
| Day High | 6.47 |
| Day Low | 6.14 |
| 52-Week High | 22.25 |
| 52-Week Low | 5.54 |
| Volume | 298,224 |
| Average Volume | 484,218 |
| Market Cap | 116.51M |
| PE | 23 |
| EPS | 0.27 |
| Moving Average 50 Days | 6.6 |
| Moving Average 200 Days | 12.91 |
| Change | -0.23 |
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
GlobeNewswire Inc.
Feb 05, 2026 1:00 PM GMT
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
GlobeNewswire Inc.
Jan 07, 2026 1:00 PM GMT
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectivenessWALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
GlobeNewswire Inc.
Dec 17, 2025 9:30 AM GMT
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of hea